Literature DB >> 7683847

A radiochemical assay for aminopeptidase N.

J W Ryan1, A Y Chung, J A Nearing, F A Valido, C Shun-Cun, P Berryer.   

Abstract

We developed an assay for aminopeptidase N (AmN) in which substrate, Arg-Phe-[3H]anilide (24.9 Ci/mmol), can be used at concentrations (1-200 nM) well below Km (12 microM) and at or below enzyme concentration ([E]). Such reaction conditions simulate those in vivo where peptide hormones in picomolar concentrations (<< Km) are degraded by nano- or micromolar concentrations of enzyme. The Arg-Phe-[3H]anilide:AmN reaction obeyed first-order enzyme kinetics when human serum, human seminal plasma, guinea pig serum, or homogeneous porcine kidney AmN was used as enzyme source and substrate was within the concentration range of 1-200 nM. For porcine AmN, kcat/Km was 1.47 x 10(9) M-1 min-1, kcat 17,640 min-1. Human serum AmN was in a concentration (about 4.6 nM) in great excess over those reported for substrates such as angiotensin III. Several advantages accrue under conditions of first-order enzyme kinetics: (1) Vmax/Km is measured directly. (2) When kcat/Km is known, [E] can be computed in mol/liter. (3) IC50 values for alternative substrates can be taken as Km values. (4) IC50 values for inhibitors are Ki values when Ki >> [E]. Arg-Phe-[3H]anilide can be used to measure AmN activity in the presence of chromophores and fluorophores that interfere with photometric and fluorometric assays. We have confirmed that alleged substrates such as angiotensin III and Met-Lys- and Lys-bradykinin are bound by AmN with high affinities (Km values, 5.7, 9.1, and 14.3 microM). Bovine pulmonary artery endothelial cell cultures were found to possess AmN-like activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7683847     DOI: 10.1006/abio.1993.1145

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  3 in total

1.  Network modeling reveals steps in angiotensin peptide processing.

Authors:  John H Schwacke; John Christian G Spainhour; Jessalyn L Ierardi; Jose M Chaves; John M Arthur; Michael G Janech; Juan Carlos Q Velez
Journal:  Hypertension       Date:  2013-01-02       Impact factor: 10.190

2.  Neutral endopeptidase activity is not elevated in serum in children with cholestatic liver disease: a unique role of aminopeptidase-m in sequential hydrolysis of peptides.

Authors:  Roman M Janas; Jerzy Socha; Jadwiga Janas; Krzysztof Warnawin
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

3.  Further studies on aminopeptidase-M in blood in children with cholestatic liver diseases and viral hepatitis.

Authors:  R M Janas; J Socha; K Warnawin; J Rujner
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.